Rituximab

CAS 174722-31-7Biologic

Overview

Rituximab is a chimeric monoclonal antibody that targets the CD20 antigen on B lymphocytes, used primarily in the treatment of certain autoimmune diseases and types of cancer such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

Therapeutic areas

OncologyImmunology
Verified Supplier Partner

Do you supply Rituximab? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Related APIs

Lenalidomide
17 suppliers
Ibrutinib
16 suppliers
Thalidomide
9 suppliers
Paclitaxel
29 suppliers
Anastrozole
25 suppliers
Capecitabine
25 suppliers
Deferasirox
24 suppliers
Palbociclib
24 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.

Start free trialBook a demo